Meanwhile, considering the huge heterogeneity and lack of effective tumor biomarkers in HCCs, the expression levels of FATP5 may be identified as a novel metabolic marker to distinguish different subtypes of HCCs. Here, SLC27A5 is linked to neoplasm.